Multi-cellular natural killer (NK) cell clusters enhance NK cell activation through localizing IL-2 within the cluster

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Kim, Miju ^a,b   Kim, Tae Jin ^c   Kim, Hye Mi ^a   Doh, Junsang ^a   Lee, Kyung Mi ^c,d  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b Amore Pacific RandD Centre   (South Korea)

^c Korea University College of Medicine   (South Korea)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA;

ANIMAL; C57BL MOUSE; CELL AGGREGATION; CELL COMMUNICATION; CELL POLARITY; CELL PROLIFERATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MICROTUBULE ORGANIZING CENTER; NATURAL KILLER CELL; SIGNAL TRANSDUCTION; SINGLE CELL ANALYSIS;

ANIMALS; CELL AGGREGATION; CELL COMMUNICATION; CELL POLARITY; CELL PROLIFERATION; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE, INBRED C57BL; MICROTUBULE-ORGANIZING CENTER; SIGNAL TRANSDUCTION; SINGLE-CELL ANALYSIS;

EID: 85009170692     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep40623     Document Type: Article

References (39)

1. Lodoen, M. B., Lanier, L. L. Natural killer cells as an initial defense against pathogens. Current Opinion in Immunology 18, 391-398, doi: 10.1016/j.coi.2006.05.002 (2006).
2. Vivier, E., Tomasello, E., Baratin, M., Walzer, T., Ugolini, S. Functions of natural killer cells. Nature Immunology 9, 503-510, doi: 10.1038/ni1582 (2008).
3. Long, E. O., Sik Kim, H., Liu, D., Peterson, M. E., Rajagopalan, S. In Annual Review of Immunology Vol. 31, 227-258 (2013).
4. Lanier, L. L. Up on the tightrope: Natural killer cell activation and inhibition. Nature Immunology 9, 495-502, doi: 10.1038/ni1581 (2008).
5. Vivier, E. et al. Innate or adaptive immunity The example of natural killer cells. Science 331, 44-49, doi: 10.1126/science.1198687 (2011).
6. Girard, J. P., Moussion, C., Förster, R. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nature Reviews Immunology 12, 762-773, doi: 10.1038/nri3298 (2012).
7. Mebius, R. E., Kraal, G. Structure and function of the spleen. Nature Reviews Immunology 5, 606-616, doi: 10.1038/nri1669 (2005).
8. Mortier, E., Woo, T., Advincula, R., Gozalo, S., Ma, A. IL-15R chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. Journal of Experimental Medicine 205, 1213-1225, doi: 10.1084/jem.20071913 (2008).
9. Degli-Esposti, M. A., Smyth, M. J. Close encounters of different kinds: Dendritic cells and NK cells take centre stage. Nature Reviews Immunology 5, 112-124, doi: 10.1038/nri1549 (2005).
10. Kang, S. J., Liang, H. E., Reizis, B., Locksley, R. M. Regulation of Hierarchical Clustering and Activation of Innate Immune Cells by Dendritic Cells. Immunity 29, 819-833, doi: 10.1016/j.immuni.2008.09.017 (2008).
11. Bajénoff, M. et al. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. Journal of Experimental Medicine 203, 619-631, doi: 10.1084/jem.20051474 (2006).
12. Gasteiger, G. et al. IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells. The Journal of experimental medicine 210, 1167-1178 (2013).
13. Martin, J. F., Perry, J. S. A., Jakhete, N. R., Wang, X., Bielekova, B. An IL-2 paradox: Blocking CD25 on T cells induces IL-2-driven activation of CD56bright NK cells. Journal of Immunology 185, 1311-1320, doi: 10.4049/jimmunol.0902238 (2010).
14. Pandiyan, P., Zheng, L., Ishihara, S., Reed, J., Lenardo, M. J. CD4 + CD25 + Foxp3 + regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4 + T cells. Nature immunology 8, 1353-1362 (2007).
15. Bihl, F., Germain, C., Luci, C., Braud, V. M. Mechanisms of NK cell activation: CD4 + T cells enter the scene. Cellular and Molecular Life Sciences 68, 3457-3467, doi: 10.1007/s00018-011-0796-1 (2011).
16. Doh, J., Krummel, M. F. In Current Topics in Microbiology and Immunology Vol. 340, 25-50 (2010).
17. Gérard, A., Beemiller, P., Friedman, R. S., Jacobelli, J., Krummel, M. F. Evolving immune circuits are generated by flexible, motile, and sequential immunological synapses. Immunological Reviews 251, 80-96, doi: 10.1111/imr.12021 (2013).
18. Sabatos, C. A. et al. A Synaptic Basis for Paracrine Interleukin-2 Signaling during Homotypic T Cell Interaction. Immunity 29, 238-248, doi: 10.1016/j.immuni.2008.05.017 (2008).
19. Gérard, A. et al. Secondary T cell-T cell synaptic interactions drive the differentiation of protective CD8 + T cells. Nature Immunology 14, 356-363, doi: 10.1038/ni.2547 (2013).
20. Lee, K. M. et al. Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions. Blood 107, 3181-3188, doi: 10.1182/blood-2005-01-0185 (2006).
21. Doh, J., Kim, M., Krummel, M. F. Cell-laden microwells for the study of multicellularity in lymphocyte fate decisions. Biomaterials 31, 3422-3428, doi: 10.1016/j.biomaterials.2010.01.018 (2010).
22. Kim, T. J. et al. Homotypic NK cell-to-cell communication controls cytokine responsiveness of innate immune NK cells. Scientific Reports 4, doi: 10.1038/srep07157 (2014).
23. Minami, Y., Kono, T., Miyazaki, T., Taniguchi, T. The IL-2 receptor complex: its structure, function, and target genes. Annual review of immunology 11, 245-268 (1993).
24. Kim, H. P., Imbert, J., Leonard, W. J. Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. Cytokine & Growth Factor Reviews 17, 349-366 (2006).
25. Ma, A., Koka, R., Burkett, P. In Annual Review of Immunology Vol. 24, 657-679 (2006).
26. Dustin, M. L., Long, E. O. Cytotoxic immunological synapses. Immunological Reviews 235, 24-34, doi: 10.1111/j.0105-2896.2010.00904.x (2010).
27. Fooksman, D. R. et al. In Annual Review of Immunology Vol. 28, 79-105 (2010).
28. Orange, J. S. Formation and function of the lytic NK-cell immunological synapse. Nature Reviews Immunology 8, 713-725 (2008).
29. James, A. et al. Rapid activation receptor-or IL-2-induced lytic granule convergence in human natural killer cells requires Src, but not downstream signaling. Blood (2013).
30. Herz, J. et al. Acid sphingomyelinase is a key regulator of cytotoxic granule secretion by primary T lymphocytes. Nature Immunology 10, 761-768, doi: 10.1038/ni.1757 (2009).
31. Kim, N. et al. MicroRNA-150 regulates the cytotoxicity of natural killers by targeting perforin-1. Journal of Allergy and Clinical Immunology 134, doi: 10.1016/j.jaci.2014.02.018 (2014).
32. Bryceson, Y. T., March, M. E., Barber, D. F., Ljunggren, H. G., Long, E. O. Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. Journal of Experimental Medicine 202, 1001-1012, doi: 10.1084/jem.20051143 (2005).
33. Kobayashi, H. et al. Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance. Blood 105, 721-727, doi: 10.1182/blood-2003-12-4187 (2005).
34. Lucas, M., Schachterle, W., Oberle, K., Aichele, P., Diefenbach, A. Dendritic Cells Prime Natural Killer Cells by trans-Presenting Interleukin 15. Immunity 26, 503-517, doi: 10.1016/j.immuni.2007.03.006 (2007).
35. Burkett, P. R. et al. Coordinate expression and trans presentation of interleukin (IL)-15R and IL-15 supports natural killer cell and memory CD8 + T cell homeostasis. Journal of Experimental Medicine 200, 825-834, doi: 10.1084/jem.20041389 (2004).
36. Stonier, S. W., Schluns, K. S. Trans-presentation: A novel mechanism regulating IL-15 delivery and responses. Immunology Letters 127, 85-92, doi: 10.1016/j.imlet.2009.09.009 (2010).
37. Gaffen, S. L., Liu, K. D. Overview of interleukin-2 function, production and clinical applications. Cytokine 28, 109-123 (2004).
38. Schluns, K. S. Window of opportunity for daclizumab. Nature Medicine 17, 545-547, doi: 10.1038/nm0511-545 (2011).
39. Wuest, S. C. et al. A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy. Nature Medicine 17, 604-609, doi: 10.1038/nm.2365 (2011).